版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、Global Research11 March 2020China Equity Model PortfolioUBS Evidence Lab inside: Fine-tuning amid uncertain market conditionsLower GDP growth may trim index EPS, but other factors may lend support Today, UBSs China macro team adjusts 2020 China GDP growth estimate from 5.4% to 4.8%, CPI from 3.3% to
2、 2.8%, nominal GDP growth from 6.7% to 6%, and Chinas 10-year government bond yield to 2.6%. Noting that listed EPS estimates are sensitive to nominal GDP growth and valuation multiples are sensitive to free risk rate, we trim our 2020 YoY EPS growth estimates for the CSI 300 and MSCI China from 10%
3、 to 9% and from 11% to 10%, respectively. Our index targets are unchanged on slight multiple expansion: CSI 300 (5,000/4,400/3,600 for upside/base/downside) and MSCI China (103/93/74 for upside/base/downside). Lower interest rates and commodity prices are fundamentally positive for Chinas economy. I
4、n H218-H119, the CSI 300 and MSCI China posted financial/non-financial net income of Rmb2.0/1.0trn and Rmb2.4/1.9trn, respectively. Our sensitivity analysis shows every 50bp cut in the lending rate on non-financial sectors debt will save Rmb1.26trn in annual interest payment.Our four investment them
5、es on track based on UBS Evidence Lab dataOur 2020 year-ahead report noted reform and innovation as main themes for China, both of which are being accelerated by the epidemic. Our four investment themes remain on track: 1) sector leaders, 2) LPR cut beneficiaries, 3) local innovators, and 4) SOE equ
6、ity incentive proxies. We provide updates on these themes backed by UBS Evidence Lab data in this report. 1) Rising SME/consumer credit risks as the outlook for jobs/income/SME viability weakens post the epidemic, 2) Accelerating innovations as Chinese governments will invest more in digital/IT infr
7、astructure and Chinese consumers are becoming more wired to the internet owing to the epidemic. 3) Beneficiaries of LPR cuts: we raise exposure to domestic market-focused value companies with high leverage, solid dividend yield, and positive EPS growth YoY in 2020 per UBS estimates. At Rmb15trn, tot
8、al interest expense paid by Chinas non- financials in 2019 equated to c80% of Chinas fiscal revenue and similar to total infrastructure investment (excluding electricity grid investments).Fine-tuning portfolio: overall constructive, interim peak likely in AprilWe forecast Chinese equities (A+H+US) t
9、o reach an interim peak in April/May on robust liquidity and easing measures. Further into 2Q, global demand and supply chain concerns may favour Chinas domestic-focused names. As of 9 March 2020, our model portfolio HYPERLINK l _bookmark0 (Figure 15) returned 0.3% YTD vs -6.3% for MSCI China, with
10、cumulative return since January 2019 at 21.6%, vs MSCI Chinas 16.4% HYPERLINK l _bookmark1 (Figure 17).ChinaEquity StrategyWendy Liu Strategist HYPERLINK mailto:wendy.m.liu wendy.m.liu+852-3712 3785Erin Zhang Strategist S1460519010002 HYPERLINK mailto:xiaoning.zhang xiaoning.zhang+86-213-866 8544Pul
11、an Li Associate Analyst HYPERLINK mailto:pulan.li pulan.li+852-2971 5578Lei Meng Strategist S1460517080001 HYPERLINK mailto:lei.meng lei.meng+86-213-866 8939(old)(new)MXCNConsumerXingyu(+), Midea, Li Ning(+), Anta(+), Wens(+), WH Group(+), GSX, TAL, Hualan Bio, Sino Biopharm, PAGD, Mindray18.1%20.3%
12、16.4%OWFinancialsPSBC(+), Huatai-H, Ping An, CPIC-H, PICC P&C, COLI, Vanke, Poly Property Mgt(+), Country Garden Srv(+)13.4%17.0%25.1%UWCyclicalsEstun, NARI(+), CNBM, Yuhong, SZ Airport11.2%7.9%10.2%UWITAlibaba, Tencent, PDD(-), NetEase, iQiyi, Meituan(+), JD(+), Bilibili(+), Dahua, Wuxi Lead(+), Yo
13、nyou(+)46.1%45.5%42.3%OWDefensivesChina Mobile, China Tower, CCS(+),China Telecom(+),CR Power, Datang-H(+),Huaneng-H(+),Yangtze Power ,SZ Gas6.3%9.1%6.0%OWCash5.0%0.2%-CategoryModel portfolio stock picks ( +/-1% weight changes and newly added stocks denoted)WeightWeightMXCNRel.Note: * Our model port
14、folio sector weighting is based on our top-down views and the availability of stock picks. * For consumer-related sectors, we overweight education and healthcare. Source: UBS estimates HYPERLINK /investmentresearch /investmentresearchThis report has been prepared by UBS Securities Asia Limited. ANAL
15、YST CERTIFICATION AND REQUIRED DISCLOSURES BEGIN ON PAGE 29. UBS does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consi
16、der this report as only a single factor in making their investment decision.2020E index targets: lower nominal GDP growth to trim index EPS, but other factors to lend supportMSCI China: MSCI China declined from the recent peak of 87.5 on 17 February to80.22 as of 9 March 2020, partly amid market fea
17、rs concerning the spread of COVID-19 around the globe and the resultant disruption to the global demand, global supply chain and global growth and the largest single day percentage decline in crude prices since 1991 over March 9th.Our bottom-up estimates on MSCI China EPS YoY growth in 2020 now stan
18、d at 10% in our base case, 100bp lower from the 11% we previously forecast. That said, we believe more abundant liquidity and lowered yield on Chinas 10-year government bond could support valuation expansion, and thus we leave our year- end targets unchanged.We understand from our sector analysts th
19、at as many listcos have not changed their full-year sales targets, potential downside from the COVID-19 outbreak is yet to be fully reflected in 2020 EPS estimates. Historical data suggest that every 100bp decline in Chinas nominal GDP corresponds with a 150bp decline in MSCI Chinas EPS YoY growth.
20、As the UBS China economics team has revised down its 2020E nominal GDP growth estimate to 6% from 6.74%, MSCI China EPS YoY growth may take a 111bp hit. We believe this is well captured by the 6% YoY EPS growth assumption in our downside case, which also assumes additional uncertainty from the China
21、-US trade friction.Figure 1: MSCI China year-end target forecastMSCI China (MXCN)103+14%15.8xUpside:+28%93+10%14.8xBase:+16%80.2274+6%12.2xDownside: -8%as of 9 Mar 2020Year- end target110105100959085807570652020E EPSy-y2020EP/E implied201820192020Source: Thomson Reuters, Datastream, UBS estimatesCSI
22、 300: The A-share market fell sharply on the first trading day after the Chinese New Year (CNY) holiday due to the coronavirus outbreak, then gradually stabilised and rebounded on declining new cases and eased liquidity conditions. Despite the recent global market volatility, A-shares have been rela
23、tively resilient as the virus looks to have been contained in China. A higher level of work resumption along with strong retail investment sentiment has supported the market, in our view.Historical data suggests that for every 1% decline in Chinas nominal GDP growth, CSI 300s EPS growth could declin
24、e by 3.5%. Our bottom-up estimate of CSI 300 EPS YoY growth in 2020 now stands at 7% in our base case, 300bp lower than the 10% previously forecast. We maintain our year-end target for CSI 300 at 4,400, as we expect lower rates and policy support could lift valuations. Q1 economic and earnings data
25、will be released from mid-April. We expect downward earnings revisions in the upcoming earnings season, as we believe sell-side analysts have yet to fully reflect the impact of the outbreak on earnings in 2020E.Figure 2: CSI 300 year-end target forecastSource: Wind, UBS estimates2523211917151311975
26、Figure 3: MSCI China: FY1 PEFigure 4: CSI 300: trailing PE+1 SD 14.2xCurrent 12.2x Median 11.8x-1 SD 9.3xSource: IBES, Datastream, UBSSource: Wind, UBSFigure 5: MSCI China: FY1 P/BVFigure 6: CSI 300: trailing P/BV4.5x4.0 x3.5x3.0 x2.5x2.0 x 1.5x+1 SD 2.0 xCurrent 1.6x Median 1.5x1.0 x0.5x0.0 x -1 SD
27、 1.1xSource: IBES, Datastream, UBSSource: Wind, UBSHang Seng Index (HSI): The HSI index is a hybrid of Chinese equities and local HK equities. Similarly to the MSCI-China, we trim index-level 2020E EPS growth forecast in the upside/base cases by around -1% to 5.5%/3.5 from 6.4%/4.5%. But we slightly
28、 expand P/E multiple in anticipation of better liquidity and lower yield outlook. The PE multiple in our upside case (11.5x) is at its historical median since end-2007 (c11.4x), while the PE multiple in our downside case is at around half of a standard deviation below the historical mean.Figure 7: H
29、ang Seng index year-end target forecastHang Seng Index36,00034,0002020E EPSgrowth2020Eimplied PE32,00030,0005.5%11.5xUpside:18%28,2003.5%11.1xBase:11%25,2001.5%10.1xDownside:-1%30,00028,00026,00024,00022,00025392.51 (as of10 March 2020)2018201920202020E YE index targetSource: Thomson Reuters, Datast
30、ream, UBS estimatesMSCI Hong Kong (MXHK): For the MXHK, we reiterate our view in our 2020 year-ahead outlook note that we are cautious on both the valuation and the asset value of the MXHK constituents. We reiterate our 2020 year-end index targets at 14,500/15,700/13,000 for base/upside/downside sce
31、narios, implying 1.11x/1.15x/ 1.02x 2020E P/BV.Figure 8: MSCI Hong Kong year-end index target forecastMSCI Hong Kong14210.9March3 (as of 92020)18,00017,50017,00016,50016,0002020EBPS growth2020Eimplied P/BV15,50015,00014,50014,00013,50013,00012,50015,70014,50013,0004.0%1.15x2.0%1.11x-1.0%1.02xUpside:
32、Base:Downside:+10%2%-9%201820192020Source: Thomson Reuters, Datastream, UBS estimates2020E YE index targetFigure 9: HSI: FY1 PEFigure 10: MSCI Hong Kong: FY1 PE23211917151311975 13.3x (+1SD)11.4x (Median) 10.8x (Current)9.4x (-1SD)17.6x (+1SD)232119171513 1197515.8x (Median) 14.9x (Current)13.9x (-1
33、SD)Source: IBES, Datastream, UBSSource: IBES, Datastream, UBSFigure 11: HSI: FY1 P/BVFigure 12: MSCI Hong Kong: FY1 P/BV3.532.52 1.51 0.501.68x (+1SD)1.34x (Median) 1.14x (Current) 0.99x (-1SD)1.49x (+1SD)2.521.5 1 0.501.28x (Median)1.11x (Current) 1.07x (-1SD)Source: IBES, Datastream, UBSSource: IB
34、ES, Datastream, UBSFigure 13: HSI: FY1 dividend yieldFigure 14: MSCI Hong Kong: FY1 dividend yield7.0%7.0%6.0%6.0%5.0%5.0%4.0% 4.0% (+1SD)3.7% (Current)4.0% 4.0% (+1SD)3.5% (Median)3.0% 3.5% (Median)3.1% (-1SD)3.0% 3.4% (Current)3.1% (-1SD)2.0%2.0%1.0%1.0%Source: IBES, Datastream, UBSSource: IBES, D
35、atastream, UBSKey changes to UBS China equity model portfolioOne apparently permanent change in China post the epidemic is that the government (both central and local) will likely invest more in the digital/IT infrastructure necessary to improve public services. Meanwhile, Chinese consumers are goin
36、g through a digitalisation boot camp with likely lasting changes. We add data/ultra-high voltage equipment, selected online service platforms, enterprise software, and property management service providers to our model portfolio.We selectively add domestic-market focused value plays with high levera
37、ge, high yield, and positive EPS growth in 2020 per our analyst estimates. IPPs and telcos are represented for this purpose.As the coronavirus spreads globally, we prefer listings with large China domestic-market focus and limited overseas exposure to avoid potential weakness in overseas demand.We a
38、dd one SOE bank to our model portfolio for its lower valuation, stronger yield and higher EPS growth over joint stock banks in 2020, based on our analyst forecasts.The UBS Evidence Lab data indicates greater-than-expected willingness to buy autos post the epidemic plus heightened awareness of EV, pa
39、rticularly Tesla, which we also express in this round of model portfolio adjustment.Figure 15: UBS China equity model portfolio as of 9 March 2020RICCompany NameWeighting*Old (9 MarMXCN2020)+/-%*(Pro- forma)Mkt cap 3m ADT (USD (USDbn)mn)UBS RatingClose price (LC)UBS TP (LC)PER (x)19E20EPBR (x)19E 20
40、EEPS (CNY)19E20EEPS growth (%)19E20EDiv Yld19EConsumer16.4%18.1%20.3%2238.HKGuangzhou Automobile1.6%-1.6%3.532Buy8.81.0-%601799.SS Xingyu Lighting1.8%1.8%4.121Buy103.1118.038.531.03.3%2313.HKShenzhou2.3%-2.3%19.241Buy99.1127.014.6
41、19.82.0%000333.SZ Midea Group2.4%1.5%55.7236Buy55.363.016.714.62.9%2331.HKLi Ning0.5%6.941Neutral21.826.533.60.60.796.021.00.8%2020.HKAnta Sports Products1.0%1.0%22.175Buy63.788.728.02.02.7%300498.SZ Wens Foodstuff Group2.0%2.0%26.5167Buy34.751.713.1
42、6.04.0255.6117.35.1%0288.HKWH Group1.5%2.0%15.038Buy7.99.513.039.24.6%EducationGSX.NGSX1.6%2.0%9.730Buy40.640.075.230.929.7174.6143.2-TAL.NTAL*2.5%2.5%32.454Buy54.768.065.442.012.428.556.1-Health Care002007.SZHualan Biological2.2%1.5%8.6129Buy42.842.041
43、.61.01.0%1177.HKSino Biopharm2.1%1.5%18.467Buy11.413.234.00.30.325.014.30.4%1833.HKPAGD1.5%2.0%10.061Buy72.890.0-54.6-107.06.111.4-0.7-0.619.511.50.0%300760.SZShenzhen Mindray1.9%2.0%45.4170Buy259.2283.068.055.117.024.723.40.4%Financials25.1%13.4%17.0%Banks16
44、58.HKPSBC3.0%3.0%12.718Buy5.00.8%Securities6886.HKHuatai - H2.5%2.5%3.014Buy13.417.80.91.01.059.04.33.7%Insurance2318.HKPing An Insurance2.9%2.5%81.4384Buy85.0115.0%2601.HKCPIC - H1.4%1.5%8.754Buy24.335.0%
45、2328.HKPICC P&C2.4%1.5%23.227Buy6.21.055.55.03.8%Real Estate0688.HKCOLI2.0%1.5%36.355Buy25.84.217.918.84.6%000002.SZChina Vanke2.3%1.5%43.1386Buy30.83.9%6049.HKPoly Property Development1.5%1.5%4.827Buy67.074.736.61.61.3-52.
46、0-20.30.4%6098.HKCountry Garden Services1.5%1.5%10.723Buy30.833.847.938.613.451.826.90.5%Cyclicals10.2%11.2%7.9%Industrials0586.HKConch Venture1.0%-1.0%8.724Buy37.543.018.55.01.7%603338.SSZhejiang Dingli1.7%-1.7%3.421Buy67.882.441.91.62.325.839.30.4%300124.SZShe
47、nzhen Inovance1.6%-1.6%7.350Neutral29.132.348.438.06.0-16.627.60.6%002747.SZEstun1.0%0.5%1.427Buy11.914.0118.40.10.2-3.3126.80.5%600406.SSNARI Technology1.7%1.7%14.679Buy21.928.32.91.01.213.919.32.0%Materials3323.HKCNBM2.3%2.0%9.742Buy8.91.5
48、%002271.SZYuhong Waterproof1.9%2.0%7.178Buy33.335.023.91.41.738.320.41.2%Transports000089.SZShenzhen Airport1.7%1.7%2.529Neutral0.30.3-11.9-8.41.0%Internet & Tech42.3%46.1%45.5%InternetBABA.NAlibaba Group*9.6%10.0%530.3803Buy197.7275.028.048.358.125.820.3-0700
49、.HKTencent10.6%10.0%470.91016Buy383.0460.06.110.012.124.020.70.4%PDD.OPinduoduo7.7%-3.2%4.5%42.4224Buy36.546.0-63.8250.218.615.7-4.01.014.8125.7-NTES.ONetEase6.9%6.0%41.5247Buy321.3370.014.918.03.33.4120.5123.0%IQ.OiQIYI3.4%4.0%14.5178Buy20.026.0-11.3-16.011.932.8-12.2-8.623.029
50、.30.0%3690.HKMeituan Dianping2.0%2.0%64.6339Buy98.8110.0153.30.51.5116.4195.20.0%JD.OJD.com2.0%2.0%58.5521Buy39.953.037.37.28.2%BILI.OBilibili2.0%2.0%8.1129Buy25.131.0-52.1-38.27.09.5-3.3-4.6-81.0-37.40.0%Technology0981.HKSMIC3.3%-3.3%9.4175Sell (CBE)14.310.038.8-99.7
51、1.51.00.3-0.166.5-136.8-601231.SS USI2.2%-2.2%6.6133Buy21.023.036.351.50.01002236.SZ Dahua2.4%2.5%8.4190Buy19.526.118.71.01.420.031.50.01300450.SZ Wuxi Lead1.5%1.5%6.3146Buy49.363.543.31.11.616.839.20.6%600588.SS Yonyou1.0%1.0%16.3187Buy45.350.0110.897.815.914
52、.30.40.566.613.20.5%Defensives6.0%11.4%9.1%Telecom0941.HKChina Mobile (HK)1.4%0.8%153.2170Buy58.280.0-9.42.05.5%0788.HKChina Tower1.1%1.0%43.0106Buy1.92.41.60.00.081.731.71.0%0552.HKCCS1.0%1.0%5.414Buy6.17.311.910.73.0%0728.HKChina Telecom0.8%29.027Buy
53、0.20.3-5.04.74.6%IPPs0836.HKChina Resources Power0.9%1.0%5.78Buy47.26.4%0991.HKDatang International Power1.0%1.0%0.91Buy1.21.9-8.4130.82.5%0902.HKHuaneng Power International1.0%1.0%1.813Buy3.05.57.00.40.6168.756.510.4%Renewabl
54、e energy600900.SSYangtze Power1.5%1.0%55.958Buy17.623.617.41.01.1-%Gas601139.SSShenzhen Gas1.5%1.5%2.814Buy6.79.416.013.92.017.414.52.6%Cash5.1%-4.9%0.2%Autos, Auto Parts & TrucksConsumer DiscretionaryConsumer StaplesNote: Share prices of A-shares and HK-listed stocks as
55、 of 10 March 2020. Share prices of US ADRs as of 9 March 2020. Past performance is not an indication of future results. Valuation and estimates are based on UBS forecasts. *Only weighting changes over 1% are displayed. * For Alibaba and TAL, valuations and forecasts are for 2020-21.Source: Thomson R
56、euters, Datastream, UBS estimatesFigure 16: Sector weightings after our latest adjustment OW UW UW OW OW60%ConsumerFinancialsCyclicalsInternet& TechDefensives50%40%Latest model portfolio weightingBenchmark weighting30%20%10%0%Note: Benchmark refers to MSCI China. Benchmark weighting data as of 9 Mar
57、ch 2020. Source: Thomson Reuters, Datastream, UBS estimatesFigure 17: Model portfolio performance since initiationFigure 18: Tracking indicatorsPortfolio: 21.6%MXCN: 16.4%(as of 09-Mar-2020)40%35%30%25%20%15%10%5%0%-5%Alpha0.04-0.040.04Beta0.670.740.65Mean excess return7.99-64.29306.29Information ra
58、tio0.43-4.5813.54Tracking Error13.1211.3512.63 TotalBullBear Note: The performance returns are based on total return (capital appreciation plus dividends) but excluding transaction costs such as commissions, fees, margin interest and interest charges. Actual transactions adjusted for such transactio
59、n costs will result in reduced total returns. Prices of stocks in this performance reflect closing prices. A complete record of all the recommendations upon which the report is based is available from UBS upon written request. Past performance is not a reliable indicator of future results. Data as o
60、f 9 March 2020.Source: Bloomberg, Datastream, UBS estimatesNote: We use MCHI US as a proxy to MSCI China for tracking indicator calculation. The performance returns are based on total return (capital appreciation plus dividends) but excluding transaction costs such as commissions, fees, margin inter
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 范文市场方案四篇
- 春节日记范本五篇
- 2024-2030年盐酸莱克多巴胺搬迁改造项目可行性研究报告
- 2024-2030年生态水利工程公司技术改造及扩产项目可行性研究报告
- 2024-2030年版中国吸氧机行业发展动态及未来投资策略研究报告
- 2024年生物质能研发与技术转让合同
- 2024全新诊所护士护理团队建设与协作合同3篇
- 2024塔吊设备租赁与操作人员培训服务合同样本3篇
- 延时辅导特色课程设计
- 楚雄校本课程设计公司
- apt攻击专项应急预案
- 小学三年级秋季学期《道德与法治》(统编版)学习任务单(全册汇总)
- 奥迪A7L汽车说明书
- 美育-美即生活 美育期末试卷及答案
- 网站项目功能测试验收报告
- 自考02313电力系统微型计算机继电保护历年(12-19)真题试卷
- 马克思主义基本原理智慧树知到答案章节测试2023年重庆工商大学
- 合理性、先进性的证明
- 人教版数学三年级上册分数的初步认识分数的初步认识-课件16
- 选必中第一单元大单元教学设计
- GB/T 34281-2017全民健身活动中心分类配置要求
评论
0/150
提交评论